Iterum Therapeutics Plc (ITRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 6,829 | 4,874 | 6,987 | 5,847 | 4,644 |
| Operating Income | -6,829 | -4,874 | -6,987 | -5,847 | -4,644 |
| Interest Expense | 772 | 849 | 980 | 2,952 | 4,243 |
| Other Income | 3,590 | 9,816 | 15,887 | -90,062 | -2,275 |
| Pre-tax Income | -4,011 | 4,093 | 7,920 | -98,861 | -11,162 |
| Income Tax | 171 | 352 | 122 | 60 | 24 |
| Net Income Continuous | -4,182 | 3,741 | 7,798 | -98,921 | -11,186 |
| Net Income | $-4,182 | $3,741 | $7,798 | $-98,921 | $-11,186 |
| EPS Basic Total Ops | 2.82 | 0.31 | 0.60 | -12.14 | 4.65 |
| EPS Basic Continuous Ops | 2.84 | 0.31 | 0.65 | -12.20 | 4.75 |
| EPS Diluted Total Ops | 2.85 | 0.28 | 0.60 | -12.14 | 4.65 |
| EPS Diluted Continuous Ops | 2.95 | 0.28 | 0.57 | -12.20 | 4.75 |
| EBITDA(a) | $-4,595 | $-4,144 | $-6,157 | $-3,440 | $-1,494 |